HCC tumours exhibit immune suppression through multiple mechanisms, including the upregulation of immune checkpoint molecules such as PD-1, CTLA-4 and TIM-3, which contribute to T-cell exhaustion [15]. The gene discussed is CTLA4; the disease is hepatocellular carcinoma.